These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 16984117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW.
    Cancer Res; 2006 Jul 01; 66(13):6732-40. PubMed ID: 16818648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.
    Tran T, Engfeldt T, Orlova A, Sandström M, Feldwisch J, Abrahmsén L, Wennborg A, Tolmachev V, Karlström AE.
    Bioconjug Chem; 2007 Jul 01; 18(6):1956-64. PubMed ID: 17944527
    [Abstract] [Full Text] [Related]

  • 6. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY.
    Cancer Res; 2007 Mar 15; 67(6):2773-82. PubMed ID: 17363599
    [Abstract] [Full Text] [Related]

  • 7. PAMAM structure-based multifunctional fluorescent conjugates for improved fluorescent labelling of biomacromolecules.
    Wängler C, Moldenhauer G, Saffrich R, Knapp EM, Beijer B, Schnölzer M, Wängler B, Eisenhut M, Haberkorn U, Mier W.
    Chemistry; 2008 Mar 15; 14(27):8116-30. PubMed ID: 18752247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells.
    Miyano T, Wijagkanalan W, Kawakami S, Yamashita F, Hashida M.
    Mol Pharm; 2010 Aug 02; 7(4):1318-27. PubMed ID: 20527783
    [Abstract] [Full Text] [Related]

  • 10. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 11. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
    Dinauer N, Balthasar S, Weber C, Kreuter J, Langer K, von Briesen H.
    Biomaterials; 2005 Oct 14; 26(29):5898-906. PubMed ID: 15949555
    [Abstract] [Full Text] [Related]

  • 12. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JR.
    J Med Chem; 2005 Jun 02; 48(11):3729-35. PubMed ID: 15916424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.
    Tran TA, Ekblad T, Orlova A, Sandström M, Feldwisch J, Wennborg A, Abrahmsén L, Tolmachev V, Eriksson Karlström A.
    Bioconjug Chem; 2008 Dec 02; 19(12):2568-76. PubMed ID: 19035668
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.